Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Change in Intangibles (2016 - 2024)

Fortress Biotech (FBIO) has 7 years of Change in Intangibles data on record, last reported at $15.0 million in Q4 2024.

  • For Q4 2024, Change in Intangibles changed N/A year-over-year to $15.0 million; the TTM value through Dec 2024 reached -$5.0 million, up 75.0%, while the annual FY2024 figure was $15.0 million, 200.0% up from the prior year.
  • Change in Intangibles reached $15.0 million in Q4 2024 per FBIO's latest filing, up from -$20.0 million in the prior quarter.
  • Across five years, Change in Intangibles topped out at $15.0 million in Q4 2024 and bottomed at -$20.0 million in Q4 2022.
  • Average Change in Intangibles over 3 years is -$633333.3, with a median of $600000.0 recorded in 2020.